Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Nature|April 22, 2008
Evolution of metal hyperaccumulation required cis-regulatory changes and triplication of HMA4Marc Hanikenne, Ina N Talke, Michael J Haydon, et al.
Acta Biomaterialia|March 26, 2013
Hemocompatibility evaluation of different silver nanoparticle concentrations employing a modified Chandler-loop in vitro assay on human bloodStefanie Krajewski, Robert Prucek, Ales Panacek, et al.
Thoracic Cancer|January 15, 2016
New basic approach to treat non-small cell lung cancer based on RNA-interferenceChristina Makowiecki, Andrea Nolte, Besmire Sutaj, et al.
Current Pharmaceutical Biotechnology|May 24, 2014
The chance of small interfering RNAs as eligible candidates for a personalized treatment of prostate cancerKatharina Pietschke, Tobias Walker, Stefanie Krajewski, et al.
Molecular Therapy. Nucleic Acids|March 23, 2017
An Atelocollagen Coating for Efficient Local Gene Silencing by Using Small Interfering RNAOlivia Koenig, Dimitrios Nothdurft, Nadja Perle, et al.
Nucleic Acid Therapeutics|January 12, 2013
Small interfering RNA transfection against serum response factor mediates growth inhibition of benign prostatic hyperplasia fibroblastsAndrea Nolte, Stefan Aufderklamm, Katrin Scheu, et al.
Nucleic Acid Therapeutics|July 1, 2015
In Vitro Evaluation of a Novel mRNA-Based Therapeutic Strategy for the Treatment of Patients Suffering from Alpha-1-Antitrypsin DeficiencyTatjana Michel, Anna Kankura, Martha L Salinas Medina, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|March 15, 2014
A new strategy in the treatment of chemoresistant lung adenocarcinoma via specific siRNA transfection of SRF, E2F1, Survivin, HIF and STAT3Mircea Gabriel Stoleriu, Volker Steger, Migdat Mustafi, et al.
Pharmaceuticals (Basel, Switzerland)|February 18, 2017
RNA-Eluting Surfaces for the Modulation of Gene Expression as A Novel Stent ConceptOlivia Koenig, Diane Zengerle, Nadja Perle, et al.
Plos One|September 19, 2015
In vitro Study of a Novel Stent Coating Using Modified CD39 Messenger RNA to Potentially Reduce Stent Angioplasty-Associated ComplicationsMeike-Kristin Abraham, Andrea Nolte, Rebekka Reus, et al.
Pageof 3